Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parasite DNA synthesis enzymes refer to several classes of enzymes essential for the replication, repair, and maintenance of DNA in parasitic protozoa and helminths, including DNA polymerases, DNA topoisomerases (such as topoisomerase I, II, and apicoplast-specific DNA gyrase), thymidine kinases, and deoxyribonucleoside kinases[2][3][4][5][7]. These enzymes are responsible for the synthesis and management of nuclear, mitochondrial, and specialized organelle (e.g., kinetoplast in trypanosomatids, apicoplast in Plasmodium) DNA. Some of them, such as apicoplast DNA gyrase and kinetoplastid polymerase β, are functionally distinct from their host (human) analogs, making them promising selective drug targets for treating diseases like malaria, sleeping sickness, and leishmaniasis[2][3][5]. Inhibitors include antibacterials that target the apicoplast or mitochondrial DNA machinery, DNA-binding agents (diamidines), antifolates, and nucleoside analogs, with mechanisms ranging from inhibition of enzyme activity to disruption of DNA topology or replication[2][4][6][7]. While these enzymes are attractive for drug development due to their essential roles and divergence from host enzymes, concerns about selectivity and toxicity remain, especially for drugs that might also interact with human DNA-processing enzymes[5][6]. The term "Parasite DNA synthesis enzymes" is broad, encompassing several molecular targets rather than a single entity, so for further detail, one should specify the particular enzyme or parasite of interest for structured database entries.
Inhibition of DNA synthesis enzymes (e.g., DNA polymerase, DNA gyrase, topoisomerase) to block DNA replication or repair, leading to parasite death. DNA minor groove binding and structural perturbation by diamidines, leading to kinetoplast disintegration and cell death. Antifolates inhibit nucleotide biosynthesis, indirectly inhibiting DNA synthesis. Nucleoside analogs are incorporated into DNA, causing premature chain termination. Topological alteration and damage to unique parasite organelle DNA (kinetoplast, apicoplast).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parasite DNA synthesis enzyme.